Kim D. Southworth
CEO and Director
Mr. Southworth has 34 years of experience in business administration, management, investment banking and securities. He spent the first decade of his career in the oil and gas industry. During that time, he founded, owned and operated two oil companies, including The American Association of Oil and Gas Investors, the first national self-regulatory agency within the oil and gas industry. Subsequently, Mr. Southworth began consulting for start-up and early stage companies and served administratively in positions such as President, Chairman and CEO. As a corporate consultant, Mr. Southworth played a significant role in the start-up, funding and business plan execution stages.
In 1999, Mr. Southworth acquired Sound Solutions, Inc. He capitalized the company and managed the day-to-day operations, expanding its client base from 200 stores to over 2000 stores in less than two years. He sold the company in August 2001. Mr. Southworth, after which in 2001, became the founder and senior partner of Advanced Business Strategies, LLC, which is a Venture Catalyst firm that prepares companies for and strategically positions them to be funded, sold, merged or acquired. ABS also represent investors to perform independent third party due diligence on companies they are looking to fund. Mr. Southworth has been officers and directors of several companies including those in Ballistic armor, bio-tech and environmental technologies among others.
Mr. Southworth brings to BioAdaptives, Inc. years of experience in public companies and a strong foundation in strategic business plan development, execution, corporate capitalization, public company compliances, auditing and filing, as well as visions in future merger, joint venture and strategic alliances to increase BioAdaptives’ growth, valuation and revenue.
Dr. Edward E. Jacobs Jr.
Dr. Edward E. Jacobs, Jr., a graduate of Princeton University and Harvard Medical school, is a biotechnology consultant with over 25 years experience in biopharmaceutical and medical device development, as well as, 35 years of teaching and direct patient care. Dr. Jacobs has participated in drug development process from discovery through animal and human studies, including regulatory support for FDA and international regulatory affairs, strategic planning and investor relations.
Dr. Jacobs has extensive clinical operations experience, having executed more than 15 human trials in the US, Europe, Eastern Europe, and the Republic of South Africa. He has also served as a medical monitor and liaison for clinical investigators involved with international trials with responsibility for regulatory compliance.
After completing surgical training at Harvard and research positions at the National Heart, Lung and Blood Institute, Bethesda, Maryland, and at Saint Thomas’ Hospital Medical School, London, Dr. Jacobs was a member of the Harvard Medical School staff, combining teaching with clinical practice and research. He has also served on the Scientific Advisory Board of the Armenise-Harvard Foundation and the New England Journal of Medicine Publications Committee.
Scientifically, Dr. Jacobs has made original observations in the field of tissue oxygenation therapy and water modification. His current focus is on natural products for animal and human use, anti-ageing strategy, and primitive cell biology.
He is an author of more than 40 scientific publications and is the holder of four patents.